Active Filter(s):
Details:
The transaction represents 15 brands including Venoruton, for venous treatment; Coldrex cold remedy; Cetebe vitamin C supplements; Mebucaine sore throat range and Tavegyl allergy brand.
Lead Product(s): Troxerutin
Therapeutic Area: Cardiology/Vascular Diseases Product Name: Undisclosed
Highest Development Status: Approved Product Type: Small molecule
Recipient: GSK
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition February 24, 2020